Hangzhou Jitai Pharmaceutical Technology Co., Ltd.

Language: Chinese English

Service And Cooperation

Technology Platform

At present, 90% of the preclinical new drug molecules of global pharmaceutical companies face extremely poor bioavailability, which leads to the failure of nearly 40% of the preclinical molecular new drug development. With its artificial intelligence-driven formulation platform, METiS spans different formulation modules and designs nano-components and formulations globally with high dimensions, so as to find optimized formulation conditions more quickly, accurately, comprehensively, and intelligently. This will significantly improve the nature of drugs and increase the efficiency and success rate of key links in drug discovery and development for pharmaceutical companies.